This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pisani, G.
Right arrow Articles by Gentili, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pisani, G.
Right arrow Articles by Gentili, G.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2002, p. 4765, Vol. 40, No. 12
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.12.4765-4767.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Overestimation of the Hepatitis C Virus RNA Content of Reference Preparations by the AMPLICOR HCV Monitor Test, Version 2.0

Giulio Pisani, Karen Cristiano, Maria Wirz, Guillermo M. Bisso, and Giuliano Gentili*

Laboratory of Immunology, Istituto Superiore di Sanità, Rome, Italy

Received 19 April 2002/ Returned for modification 16 June 2002/ Accepted 25 September 2002

An evaluation of the AMPLICOR hepatitis C virus (HCV) monitor test, version 2.0 (Roche Diagnostics), was carried out to investigate whether this test overestimates the HCV RNA content of reference preparations. Satisfactory accuracy was observed when the World Health Organization HCV international standard was included in the assay and a modified formula was used to calculate the viral content.

* Corresponding author. Mailing address: Laboratory of Immunology, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy. Phone: 39-06-49902346. Fax: 39-06-49387115. E-mail: ggentili{at}iss.it.

Journal of Clinical Microbiology, December 2002, p. 4765, Vol. 40, No. 12
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.12.4765-4767.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Sabato, M. F., Shiffman, M. L., Langley, M. R., Wilkinson, D. S., Ferreira-Gonzalez, A. (2007). Comparison of Performance Characteristics of Three Real-Time Reverse Transcription-PCR Test Systems for Detection and Quantification of Hepatitis C Virus. J. Clin. Microbiol. 45: 2529-2536 [Abstract] [Full Text]  
  • Colson, P., Motte, A., Tamalet, C. (2006). Broad Differences between the COBAS Ampliprep Total Nucleic Acid Isolation-COBAS TaqMan 48 Hepatitis C Virus (HCV) and COBAS HCV Monitor v2.0 Assays for Quantification of Serum HCV RNA of Non-1 Genotypes. J. Clin. Microbiol. 44: 1602-1603 [Full Text]  
  • Konnick, E. Q., Williams, S. M., Ashwood, E. R., Hillyard, D. R. (2005). Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan Analyte-Specific Reagent Assay and Comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 Assays. J. Clin. Microbiol. 43: 2133-2140 [Abstract] [Full Text]  
  • Forman, M. S., Valsamakis, A. (2004). Verification of an Assay for Quantification of Hepatitis C Virus RNA by Use of an Analyte-Specific Reagent and Two Different Extraction Methods. J. Clin. Microbiol. 42: 3581-3588 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»